Literature DB >> 21807114

Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α.

Athanasios Karapetsas1, Antonis Giannakakis, Maria Pavlaki, Mihalis Panayiotidis, Raphael Sandaltzopoulos, Alex Galanis.   

Abstract

The mitogen activated protein kinase (MAPK) signaling pathways play significant roles in fundamental cellular processes, such as cell growth and differentiation. It has been shown that the specificity and efficacy of phosphorylation by MAP kinases rely upon distinct MAPK-docking domains (D-domains) found in a wide range of MAPK substrates including the ETS-transcription factor Elk-1. Importantly, the MAPK signaling cascade converges with the hypoxia-induced signaling pathway. The key regulator of hypoxia signaling is the heterodimeric transcription factor hypoxia inducible factor-1 (HIF-1). The α-subunit of HIF-1 (HIF-1α) is a substrate for the ERK2 MAP kinase. Unraveling the interplay of these main signaling systems is a prerequisite for understanding their role in tumor growth, a situation sustained by simultaneous mitogenic and hypoxic signals. In this work, we investigated the molecular cues that direct HIF-1α recognition and phosphorylation by ERK2. We showed that HIF-1α possesses a MAPK docking domain. Utilizing surface plasmon resonance (SPR) methodologies we demonstrated efficient binding between HIF-1α and ERK2, with a K(D) value in the low micromolar range. Although, the D-domain did not contribute to the above interaction significantly, it could act in trans by recruiting ERK2 and conferring responsiveness to poor ERK substrates. These results indicate that, via its conserved D-domain, HIF-1α could serve as a platform for ERK2 in the nucleus of the cell, thus potentially facilitating phosphorylation of other ERK2 substrates. The identification of an ERK2 recognition domain on HIF-1α opens new avenues for the analysis of HIF-1α-related ERK2 signaling and may allow designing of interfering compounds.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807114     DOI: 10.1016/j.biocel.2011.07.007

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway.

Authors:  Jun He; Xu Qian; Richard Carpenter; Qing Xu; Lin Wang; Yanting Qi; Zi-Xuan Wang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Toxicol Sci       Date:  2013-06-07       Impact factor: 4.849

2.  Endostatin exerts radiosensitizing effect in non-small cell lung cancer cells by inhibiting VEGFR2 expression.

Authors:  L Liu; Y Qiao; C Hu; Y Liu; Y Xia; L Wang; B Liu; H Chen; X Jiang
Journal:  Clin Transl Oncol       Date:  2015-11-05       Impact factor: 3.405

3.  Molecular Characterization and Expression Analysis of S6K1 in Cashmere Goats (Capra hircus).

Authors:  Wu Manlin; Bao Wenlei; Hao Xiyan; Zheng Xu; Wang Yanfeng; Wang Zhigang
Journal:  Asian-Australas J Anim Sci       Date:  2013-08       Impact factor: 2.509

Review 4.  Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases.

Authors:  Tamara Bhandari; Victor Nizet
Journal:  Infect Dis Ther       Date:  2014-06-24

Review 5.  Cell cycle progression in response to oxygen levels.

Authors:  Brian Ortmann; Jimena Druker; Sonia Rocha
Journal:  Cell Mol Life Sci       Date:  2014-05-25       Impact factor: 9.261

6.  hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors.

Authors:  Shunsuke Ohnishi; Osamu Maehara; Koji Nakagawa; Ayano Kameya; Kanako Otaki; Hirotoshi Fujita; Ryosuke Higashi; Kikuko Takagi; Masahiro Asaka; Naoya Sakamoto; Masanobu Kobayashi; Hiroshi Takeda
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

7.  Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study.

Authors:  Liling Huang; Cunxu Liu; Yan Deng; Yanqiong Liu; Jiangyang Zhao; Xiuli Huang; Wenjun Tang; Yifan Sun; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.